J01DE01 - Cefepime |
Probably not porphyrinogenic |
PNP |
Rationale
In greater part not metabolised. No clinical or experimental data pointing to CYP-interaction. Two references consider the drug safe or probably safe.
Chemical description
Parenterally administered cephalosporin used in serious pneumonia, serious infections outgoing from the lungs and serious intra-abdominal infections. About 85% is excreted in unchanged form in urine. About 8% is excreted as primary or secondary metabolites. French list: use. South African list: use with caution. See: Jordan MC et al., No induction of CYPs observed in animal study.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| 1. | Effect of the cephalosporin cefepime on hepatic drug metabolising enzyme activity in rats.
Jordan MC, Waller AR, et al. Toxicol Lett. 1994 Mar; 71(1):63-7.
|
8140590 |
Tradenames